Suchergebnisse - "Miralpeix, Anna"

PubPharm (6)

1

Influence of language barrier and cultural background in hepatitis B disease knowledge in a Chinese community of Spain

enthalten in: Frontiers in public health | 2024

von Pocurull, A. | Collazos, C. | Miralpeix, A. | +6

2

Health-Related Quality of Life in Patients Living with Wilson Disease in Spain : A Cross-Sectional Observational Study

enthalten in: Journal of clinical medicine | 2023

von Mariño, Z. | Berenguer, M. | Peña-Quintana, L. | +11

3

Usefulness of dried blood spot samples for monitoring hepatitis C treatment outcome and reinfection among people who inject drugs in a test-and-treat program

enthalten in: Journal of medical virology | 2023

von Not, A. | Saludes, V. | Gálvez, M. | +11

4

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

enthalten in: JHEP reports : innovation in hepatology | 2022

von Lens, S. | Miralpeix, A. | Gálvez, M. | +9

5

Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy

enthalten in: Journal of viral hepatitis | 2021

von Rodríguez-Tajes, S. | Miralpeix, A. | Costa, J. | +6

CommentIn: Eur J Clin Microbiol Infect Dis. 2023 Jun;42(6):799-801. - PMID 37084117

6

Effectiveness of a primary care-based intervention to reduce sitting time in overweight and obese patients (SEDESTACTIV) : a randomized controlled trial; rationale and study design

enthalten in: BMC public health | 2014

von Martín-Borràs, C. | Giné-Garriga, M. | Martínez, E. | +78

1
[1]